Q: What is Izervay used for?

Izervay is used to treat geographic atrophy secondary to age-related macular degeneration .

Q: How does Izervay work?

Targeting the Complement System Izervay is a complement C5 inhibitor. The complement system is a part of the body's immune system that normally helps fight infections and clear out damaged cells. In people with geographic atrophy (GA) secondary to age-related macular degeneration, this system can become overactive and mistakenly attack healthy cells in the retina. How Avacincaptad Pegol Works The active ingredient in Izervay, avacincaptad pegol, is designed to bind to and block a specific protein called complement C5. By inhibiting this protein, the medication prevents the immune system from producing substances that lead to inflammation and the destruction of retinal cells. This process helps to: Slow lesion growth: By reducing immune-mediated damage, the medication slows the expansion of the "dry" patches or lesions in the back of the eye. Preserve remaining vision: While the medication cannot repair existing damage or restore vision that has already been lost, it aims to slow the progression of the disease to help maintain the patient's current level of vision for a longer period.

Q: What are the active ingredients in Izervay?

The active ingredient in Izervay is avacincaptad pegol .

Q: What are the side effects of Izervay?

Common side effects of Izervay may include: eye pain vitreous floaters conjunctival hemorrhage Always consult with a healthcare professional about potential side effects.

Q: What drug class is Izervay?

Izervay belongs to the GLP-1 receptor agonist drug class.

Q: What is the dosage of Izervay and how do I take it?

Administration Izervay is given as an intravitreal injection, which means it is injected directly into the vitreous (the jelly-like substance) of the eye. This procedure is performed by a healthcare professional, such as an ophthalmologist, in a clinical setting. Before the injection, your doctor will clean your eye to help prevent infection and use a local anesthetic (numbing medicine) to reduce discomfort during the procedure. Typical Schedule The medication is usually administered once every month. Your healthcare provider will determine the appropriate length of treatment based on your condition. Missed Doses If you miss an appointment for your injection, contact your doctor as soon as possible to reschedule. After receiving the missed dose, your next injection will typically be scheduled based on the date of that treatment.

Q: Is Izervay safe during pregnancy and breastfeeding?

Pregnancy There are no adequate or well-controlled studies regarding the use of Izervay in pregnant women. It is currently unknown whether this medication can cause harm to a developing fetus or if it affects reproductive capacity. Because Izervay is administered directly into the eye, the amount of medication that reaches the bloodstream is very low. However, because the risks are not fully established, Izervay should be used during pregnancy only if the potential benefit to the patient outweighs the potential risk to the fetus. Breastfeeding It is not known if Izervay passes into human breast milk, if it affects milk production, or if it has any impact on a breastfed infant. While systemic absorption of the drug is minimal after an ocular injection, healthcare providers generally recommend caution. Patients who are breastfeeding or planning to breastfeed should consult with their doctor to determine if the treatment is appropriate for them.

Q: What is the FDA approval status of Izervay?

FDA Approval Status Izervay was approved by the U.S. Food and Drug Administration (FDA) on August 4, 2023. It is classified as a complement C5 inhibitor and is administered via intravitreal injection by a healthcare professional. Approved Indications The medication is approved for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). GA is an advanced form of AMD that leads to irreversible vision loss. Regulatory History and Designations The FDA granted Izervay Fast Track and Breakthrough Therapy designations during its development process. These designations are intended to accelerate the development and review of drugs that address serious conditions with unmet medical needs. The approval was supported by data from the GATHER1 and GATHER2 clinical trials, which demonstrated a reduction in the rate of GA lesion growth. Safety Requirements As of its initial approval, Izervay does not have a Boxed Warning, which is the FDA’s most serious warning for certain significant risks. There is also no Risk Evaluation and Mitigation Strategy (REMS) required for this medication. Regulatory monitoring continues through standard reporting of adverse events.

Question 1

What is Izervay?

Accepted Answer

Izervay is a medication that targets the complement system, a part of the body's immune response. It specifically binds to the C5 protein to help prevent the destruction of cells in the macula, which is the area of the eye responsible for sharp central vision.

By inhibiting this protein, the drug aims to reduce the growth of lesions that cause permanent vision loss. This approach focuses on managing the underlying biological processes that lead to the death of light-sensing tissues in the retina.

Question 2

What is Izervay used for?

Accepted Answer

Izervay is used to treat geographic atrophy secondary to age-related macular degeneration.

Question 3

How does Izervay work?

Accepted Answer

Targeting the Complement System

Izervay is a complement C5 inhibitor. The complement system is a part of the body's immune system that normally helps fight infections and clear out damaged cells. In people with geographic atrophy (GA) secondary to age-related macular degeneration, this system can become overactive and mistakenly attack healthy cells in the retina.

How Avacincaptad Pegol Works

The active ingredient in Izervay, avacincaptad pegol, is designed to bind to and block a specific protein called complement C5. By inhibiting this protein, the medication prevents the immune system from producing substances that lead to inflammation and the destruction of retinal cells. This process helps to:

Slow lesion growth: By reducing immune-mediated damage, the medication slows the expansion of the "dry" patches or lesions in the back of the eye.
Preserve remaining vision: While the medication cannot repair existing damage or restore vision that has already been lost, it aims to slow the progression of the disease to help maintain the patient's current level of vision for a longer period.

Question 4

What are the active ingredients in Izervay?

Accepted Answer

The active ingredient in Izervay is avacincaptad pegol.

Question 5

What are the side effects of Izervay?

Accepted Answer

Common side effects of Izervay may include:

eye pain
vitreous floaters
conjunctival hemorrhage

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Izervay?

Accepted Answer

Izervay belongs to the GLP-1 receptor agonist drug class.

Question 7

What is the dosage of Izervay and how do I take it?

Accepted Answer

Administration

Izervay is given as an intravitreal injection, which means it is injected directly into the vitreous (the jelly-like substance) of the eye. This procedure is performed by a healthcare professional, such as an ophthalmologist, in a clinical setting.

Before the injection, your doctor will clean your eye to help prevent infection and use a local anesthetic (numbing medicine) to reduce discomfort during the procedure.

Typical Schedule

The medication is usually administered once every month. Your healthcare provider will determine the appropriate length of treatment based on your condition.

Missed Doses

If you miss an appointment for your injection, contact your doctor as soon as possible to reschedule. After receiving the missed dose, your next injection will typically be scheduled based on the date of that treatment.

Question 8

Is Izervay safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate or well-controlled studies regarding the use of Izervay in pregnant women. It is currently unknown whether this medication can cause harm to a developing fetus or if it affects reproductive capacity. Because Izervay is administered directly into the eye, the amount of medication that reaches the bloodstream is very low. However, because the risks are not fully established, Izervay should be used during pregnancy only if the potential benefit to the patient outweighs the potential risk to the fetus.

Breastfeeding

It is not known if Izervay passes into human breast milk, if it affects milk production, or if it has any impact on a breastfed infant. While systemic absorption of the drug is minimal after an ocular injection, healthcare providers generally recommend caution. Patients who are breastfeeding or planning to breastfeed should consult with their doctor to determine if the treatment is appropriate for them.

Question 9

What forms and strengths does Izervay come in?

Accepted Answer

Izervay is a sterile solution intended for administration by a healthcare professional. It is available in the following form:

Intravitreal Injection: A liquid solution provided in a vial for injection into the eye.

The solution is clear to slightly opalescent and colorless to slightly yellow. Each vial is intended for use in a single eye for one procedure.

Question 10

What is the FDA approval status of Izervay?

Accepted Answer

FDA Approval Status

Izervay was approved by the U.S. Food and Drug Administration (FDA) on August 4, 2023. It is classified as a complement C5 inhibitor and is administered via intravitreal injection by a healthcare professional.

Approved Indications

The medication is approved for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). GA is an advanced form of AMD that leads to irreversible vision loss.

Regulatory History and Designations

The FDA granted Izervay Fast Track and Breakthrough Therapy designations during its development process. These designations are intended to accelerate the development and review of drugs that address serious conditions with unmet medical needs. The approval was supported by data from the GATHER1 and GATHER2 clinical trials, which demonstrated a reduction in the rate of GA lesion growth.

Safety Requirements

As of its initial approval, Izervay does not have a Boxed Warning, which is the FDA’s most serious warning for certain significant risks. There is also no Risk Evaluation and Mitigation Strategy (REMS) required for this medication. Regulatory monitoring continues through standard reporting of adverse events.

Question 11

What should I know about Izervay and cost?

Accepted Answer

Factors Affecting Cost

The total price of treatment with Izervay can vary based on several factors. Because this medication is administered as an injection into the eye by a healthcare professional, the cost usually includes both the drug itself and the professional fees for the office visit and the procedure.

Insurance Coverage: Most private insurance plans and Medicare Part B provide coverage for Izervay, but your specific out-of-pocket costs will depend on your plan's deductible, copayment, or coinsurance requirements.
Treatment Schedule: The frequency of your injections as determined by your doctor will impact the long-term cost of therapy.
Healthcare Setting: Costs may differ depending on whether the injection is performed in a private clinic, a specialized eye center, or a hospital outpatient department.

Financial Assistance and Support

Financial assistance programs may be available to help eligible patients manage the costs of Izervay. These programs are often provided by the manufacturer and may include:

Copay Savings Programs: These are typically available for patients with commercial (private) insurance to help reduce out-of-pocket expenses.
Patient Assistance Programs: These programs may provide the medication at a lower cost or for free to patients who are uninsured or meet specific financial eligibility criteria.

To understand your specific costs, it is best to contact your insurance provider and your doctor's office for a detailed estimate based on your coverage and treatment plan.

Izervay

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Izervay

Hospitals.net Disclosure